AHA Scientific Sessions 2026 Abstract

Health profiles linked to non-cardiac death in heart failure

Non-cardiac deaths occurred in 22.4% of the multiorgan-wasting group versus 18.4% of the inflammation-and-frailty group over an average 791 days.

Paper by Tomofumi Misaka, Koji Oowada, Ryota Kusano, +12 more authorsYasuchika Takeishi · Fukushima Medical University
Heart sections beside small groups of people contrast a larger heart, kidney, and sparse muscle with a smaller heart and muscle crowded by immune cells.

Our read

Populations
Studied:
Cohort study of 2,159 hospitalized patients with stage C/D heart failure, mean 791 days
What changed:
Non-cardiac death occurred in 22.4% of the multiorgan-wasting phenotype and 18.4% of the inflammatory-frailty phenotype
The catch:
Other underlying illnesses in sicker patients may have driven the higher death risk

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

The 2,159 hospitalized patients had stage C or D heart failure, meaning they had experienced symptoms or had advanced disease. Researchers analyzed their baseline clinical characteristics in an observational study. They used a computer-based grouping method that did not use later outcomes to define the groups.

The analysis identified six profiles. A profile combining tissue wasting with heart and kidney problems included 161 patients. Another, combining inflammation, frailty and depleted nutrition, included 310. Both were strongly associated with death from non-cardiac causes over an average follow-up of 791 days. These deaths occurred in 22.4% of the first group and 18.4% of the second. The first group also had the highest rates of cardiac death and death overall.

Why it matters

Heart failure care often centers on the heart. The findings suggest that risk assessment may also need to consider broader vulnerabilities involving nutrition, inflammation and kidney function.

Caveats

Patients with poorer nutrition and organ problems may also have been sicker in other ways that affected their risk of death. The findings concern hospitalized patients with stage C or D heart failure and were reported in a conference abstract.

Comments

Be the first to comment.